The 4^th ADC Target Selection Summit was uniquely positioned for biopharma and biotech professionals looking to advance target selection and validation efforts, supercharging the revolution for more novel, clinically validated targets.

The summit equipped attendees with a ‘first-in-class’ mindset for ADC development with expert insights into target biology, computational approaches, bispecific targets, selection strategy and much more; from the likes of Abbvie, BMS, Immunome, and Epifold.

The summit was tailored for ADC professionals operating within biology, translation, discovery, bioinformatics and computational departments.